Cargando…
Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
Non-cystic fibrosis bronchiectasis (NCFB) is a severe chronic illness characterized by irreversible dilation of airways and thickening of bronchial walls, chronic inflammation, repeated infections, and progressive obstruction of the airways. In contrast to cystic fibrosis bronchiectasis (CFB), which...
Autores principales: | Chorepsima, Stamatia, Kechagias, Konstantinos S, Kalimeris, Georgios, Triarides, Nikolaos A, Falagas, Matthew E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267620/ https://www.ncbi.nlm.nih.gov/pubmed/30568427 http://dx.doi.org/10.2147/DDDT.S168014 |
Ejemplares similares
-
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
por: Wilson, Robert, et al.
Publicado: (2013) -
A Model for Out-of-Hospital Multispecialty Emergency Medicine:
Accomplishments and Challenges
por: Theocharis, George, et al.
Publicado: (2018) -
Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016) -
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment
por: Almurshedi, Alanood S, et al.
Publicado: (2021) -
Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
por: Vendrell, Montserrat, et al.
Publicado: (2015)